Industry wishes barcoding to remain on voluntary basis
This article was originally published in Clinica
The device industry has decided to oppose FDA efforts to require barcodes on medical products, preferring voluntary compliance so that companies can decide for themselves whether their products warrant identification or not. "There's not a one size fits all answer," explained Tess Castle of AdvaMed, the Advanced Medical Technology Association.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.